Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

A damaging attraction

Vasoproliferative retinopathies, such as proliferative diabetic retinopathy (PDR), are a major cause of blindness in industrialized nations. In PDR, degeneration of microvasculature in the retina results in neuroretinal ischemic stress, which then induces aberrant angiogenesis. Mononuclear phagocytes (MPs) are elevated in these diseases; however, the signals and mechanisms that mediate recruitment of innate immune cells to the retina are poorly understood. Using a murine oxygen-induced retinopathy (OIR) model of PDR, Agnieszka Dejda, Gaelle Mawambo, and colleagues at the University of Montreal determined that MPs expressing neuropilin-1 (NRP-1) localize to sites of neovascularization in the retina following OIR. The authors found that the NRP-1 ligand semaphorin 3A (SEMA3A) is elevated in patients with late-stage PDR, and in mice, both SEMA3A and NRP-1 ligand VEGF are induced in the retinal ganglion cell layer during OIR and recruit circulating NRP-1-expressing MPs. Compared to WT animals, mice with NRP-1-deficient MPs exhibited less vascular degeneration and pathological neovascularization during OIR. Moreover, intravitrial administration of soluble NRP-1 reduced MP infiltration and pathological neovascularization in OIR-induced retinopathy. The results of this study identify proangiogenic NRP-1-expressing MPs as mediators of destructive ocular inflammation and suggest that targeting NRP-1 has potential to limit neural ischemia-induced damage. The accompanying image shows a corrosion cast of normal mouse retinal vasculature imaged by environmental scanning electron microscopy (ESEM). In diabetic retinopathy, the vascular beds seen here degenerate and later proliferate and grow in a disorganized fashion.

Published October 1, 2014, by Corinne Williams

Scientific Show Stopper

Related articles

Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk
Agnieszka Dejda, … , Nathalie Labrecque, Przemyslaw Sapieha
Agnieszka Dejda, … , Nathalie Labrecque, Przemyslaw Sapieha
Published October 1, 2014
Citation Information: J Clin Invest. 2014;124(11):4807-4822. https://doi.org/10.1172/JCI76492.
View: Text | PDF
Research Article Immunology

Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk

  • Text
  • PDF
Abstract

Immunological activity in the CNS is largely dependent on an innate immune response and is heightened in diseases, such as diabetic retinopathy, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer’s disease. The molecular dynamics governing immune cell recruitment to sites of injury and disease in the CNS during sterile inflammation remain poorly defined. Here, we identified a subset of mononuclear phagocytes (MPs) that responds to local chemotactic cues that are conserved among central neurons, vessels, and immune cells. Patients suffering from late-stage proliferative diabetic retinopathy (PDR) had elevated vitreous semaphorin 3A (SEMA3A). Using a murine model, we found that SEMA3A acts as a potent attractant for neuropilin-1–positive (NRP-1–positive) MPs. These proangiogenic MPs were selectively recruited to sites of pathological neovascularization in response to locally produced SEMA3A as well as VEGF. NRP-1–positive MPs were essential for disease progression, as NRP-1–deficient MPs failed to enter the retina in a murine model of oxygen-induced retinopathy (OIR), a proxy for PDR. OIR mice with NRP-1–deficient MPs exhibited decreased vascular degeneration and diminished pathological preretinal neovascularization. Intravitreal administration of a NRP-1–derived trap effectively mimicked the therapeutic benefits observed in mice lacking NRP-1–expressing MPs. Our findings indicate that NRP-1 is an obligate receptor for MP chemotaxis, bridging neural ischemia to an innate immune response in neovascular retinal disease.

Authors

Agnieszka Dejda, Gaelle Mawambo, Agustin Cerani, Khalil Miloudi, Zhuo Shao, Jean-Francois Daudelin, Salix Boulet, Malika Oubaha, Felix Beaudoin, Naoufal Akla, Sullivan Henriques, Catherine Menard, Andreas Stahl, Jean-Sébastien Delisle, Flavio A. Rezende, Nathalie Labrecque, Przemyslaw Sapieha

×
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts